Regenerative & precision medicine
Regenerative medicine, considered carefully.
Regenerative medicine is one of the most talked-about areas of modern health, and one of the easiest to oversimplify. Alba's approach is deliberately measured.
Treatments
Personalised treatment begins with assessment.
Alba connects clients with specialist medical teams working across personalised, regenerative and precision medicine. Treatment is never selected from a generic menu. Recommendations are made following medical assessment and depend upon the individual, the available evidence, clinical suitability and the law of the country in which care is delivered.
Stem-cell treatment
A personalised pathway into regenerative medicine.
Stem-cell-based treatment is one of the principal areas in which Alba helps suitable clients navigate international medical care. Our role is to connect you with the appropriate clinical team and provide continuity around the journey. Medical assessment, suitability, consent and treatment remain with the responsible licensed clinicians.
Your pathway
01
Private conversation
A private introductory conversation with Alba.
02
Introduction
Introduction to the appropriate medical team and location.
03
Consultation
Clinical consultation and review of your health and object
04
Assessment
Diagnostics or further assessment where required.
05
Recommendation
A written recommendation explaining the proposed treatment, rationale, risks, alternatives and costs.
06
Treatment
Treatment in the appropriate licensed clinical setting, where approved.
07
Follow-up
Follow-up and monitoring determined by the treating team.
Why assessment comes first
Not one standard procedure.
The appropriate approach depends upon your health, objectives, medical history, biological findings and the condition or area being considered. Assessment allows the medical team to decide whether cellular treatment is appropriate and whether another intervention may be more suitable.
Clear medical qualification
Stem-cell-based interventions are not appropriate for everyone and should not be presented as a guaranteed cure or universal anti-ageing treatment. Availability and permitted uses differ between countries. Any proposed treatment must be assessed and explained by the responsible medical team before the client proceeds.
Programme and pricing guide
Explore programmes and pricing.
Download our private guide to the personalised longevity programmes, including programme durations, areas assessed, monitoring and indicative pricing.
Requesting the guide does not commit you to a consultation or treatment.
Our position
Access, with judgement.
We provide access to specialist medical teams working across personalised, cellular and regenerative medicine, while keeping assessment, evidence and clinical suitability at the centre of every decision.
Where a regenerative approach is considered appropriate, the treating clinician will explain what is proposed, why it is being considered, the strength of the evidence, the known risks and uncertainties, and the regulatory framework in the country where treatment is delivered.
Stem cells
What they are, and what they are not.
Stem cells are undifferentiated cells with the ability to self-renew and, depending on the cell type, develop into specialised cells. Their role in medicine varies enormously. Some stem-cell applications are established, while others remain investigational or are regulated differently between countries.
Alba does not present stem cells as a universal longevity treatment. Where cellular therapy is available through our medical network, suitability is assessed individually by the treating team and discussed within the context of the evidence and local regulation.
Other advanced interventions
Medicinal treatment stays with the clinician.
Personalised treatment may involve medical, metabolic, nutritional or regenerative approaches depending on individual findings and the jurisdiction in which care is provided. Any prescription or medicinal treatment is recommended and managed by the treating clinician.
For that reason, we discuss areas such as peptide science educationally rather than promoting named medicines, and we do not describe any intervention as guaranteed to work.
Advanced interventions may be considered only where clinically appropriate, subject to medical assessment, and where lawfully available in the country of care.